• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2基因在人类乳腺癌中的表达

Cyclooxygenase-2 gene expression in human breast cancer.

作者信息

Parrett M, Harris R, Joarder F, Ross M, Clausen K, Robertson F

机构信息

OHIO STATE UNIV,DEPT MED MICROBIOL & IMMUNOL,COLL MED,COLUMBUS,OH 43210. OHIO STATE UNIV,COLL MED,DEPT PATHOL,COLUMBUS,OH 43210. OHIO STATE UNIV,COLL MED,SCH PUBL HLTH,COLUMBUS,OH 43210. OHIO STATE UNIV,COLL MED,CTR COMPREHENS CANC,COLUMBUS,OH 43210.

出版信息

Int J Oncol. 1997 Mar;10(3):503-7. doi: 10.3892/ijo.10.3.503.

DOI:10.3892/ijo.10.3.503
PMID:21533404
Abstract

Expression of the inducible isoform of the cyclooxygenase gene (PGHS-2, COX-2) which codes for the enzyme that catalyzes formation of prostaglandins, was detected in 13/13 human breast tumors of high grade but not in samples of normal breast tissue. There was a statistically significant linear association between COX-2 gene expression and high (>50%) tumor cell density (p<0.01), with COX-2 protein localized to tumor cells. These results indicate that COX-2 gene expression may be useful as a molecular biomarker for human breast tumors and may also predict sensitivity to treatment with nonsteroidal anti-inflammatory drugs.

摘要

编码催化前列腺素形成的酶的环氧化酶基因(PGHS - 2,COX - 2)的诱导型异构体在13例高级别人类乳腺肿瘤中均有表达,但在正常乳腺组织样本中未检测到。COX - 2基因表达与高(>50%)肿瘤细胞密度之间存在统计学上显著的线性关联(p<0.01),COX - 2蛋白定位于肿瘤细胞。这些结果表明,COX - 2基因表达可能作为人类乳腺肿瘤的分子生物标志物,也可能预测对非甾体抗炎药治疗的敏感性。

相似文献

1
Cyclooxygenase-2 gene expression in human breast cancer.环氧化酶-2基因在人类乳腺癌中的表达
Int J Oncol. 1997 Mar;10(3):503-7. doi: 10.3892/ijo.10.3.503.
2
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.环氧化酶-2在人乳腺癌及相邻导管原位癌中的表达
Cancer Res. 2002 Mar 15;62(6):1676-81.
3
Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?环氧化酶-2、P-糖蛋白-170与耐药性;化学预防多重耐药是否可行?
Anticancer Res. 2001 May-Jun;21(3C):2141-7.
4
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.前列腺素G/H合酶-1和-2蛋白在人结肠癌中的表达
Cancer Res. 1995 Jun 15;55(12):2556-9.
5
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.炎症与乳腺癌。环氧化酶/前列腺素信号传导与乳腺癌。
Breast Cancer Res. 2007;9(4):210. doi: 10.1186/bcr1678.
6
Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.乳腺癌中芳香化酶与环氧化酶之间的关系:新治疗方法的潜力
Minerva Endocrinol. 2006 Mar;31(1):13-26.
7
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.环氧化酶-2在前列腺增生性炎性萎缩中上调,但在前列腺癌中未上调。
Cancer Res. 2001 Dec 15;61(24):8617-23.
8
Aromatase and COX in breast cancer: enzyme inhibitors and beyond.乳腺癌中的芳香化酶与环氧化酶:酶抑制剂及其他
J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):16-23. doi: 10.1016/j.jsbmb.2007.05.021. Epub 2007 May 25.
9
Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.环氧化酶-1和环氧化酶-2在支气管上皮和非小细胞肺癌中的表达
Cancer. 2002 Feb 15;94(4):1023-31.
10
Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.选择性环氧化酶2抑制剂氟舒林对大鼠被动性海曼肾炎的影响。
Kidney Int. 1999 Nov;56(5):1770-8. doi: 10.1046/j.1523-1755.1999.00742.x.

引用本文的文献

1
Recent advances in targeting COX-2 for cancer therapy: a review.靶向COX-2用于癌症治疗的最新进展:综述
RSC Med Chem. 2025 Apr 21. doi: 10.1039/d5md00196j.
2
Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity.激素受体信号与乳腺癌对抗肿瘤免疫的抵抗。
Int J Mol Sci. 2023 Oct 10;24(20):15048. doi: 10.3390/ijms242015048.
3
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.前列腺素E2受体4(EP4)作为阻碍乳腺癌相关血管生成和淋巴管生成的治疗靶点。
Cancers (Basel). 2021 Feb 24;13(5):942. doi: 10.3390/cancers13050942.
4
NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE Signaling Axis.抑制COX-2/PGE信号轴可降低NGF增强的上皮性卵巢癌细胞的血管生成特性。
Cancers (Basel). 2019 Dec 7;11(12):1970. doi: 10.3390/cancers11121970.
5
Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.韩国前瞻性队列中乳腺癌代谢物和代谢途径分析:韩国癌症预防研究 II。
Metabolomics. 2018 Jun 8;14(6):85. doi: 10.1007/s11306-018-1382-4.
6
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.EP4 作为侵袭性人类乳腺癌的治疗靶点。
Int J Mol Sci. 2018 Mar 29;19(4):1019. doi: 10.3390/ijms19041019.
7
Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.敲低过表达 COX-2 的乳腺癌细胞中的 delta-5-去饱和酶可通过二高-γ-亚麻酸过氧化依赖机制抑制生长、迁移和侵袭。
BMC Cancer. 2018 Mar 27;18(1):330. doi: 10.1186/s12885-018-4250-8.
8
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.挑战一个误称?炎症通路在炎性乳腺癌中的作用。
Mediators Inflamm. 2017;2017:4754827. doi: 10.1155/2017/4754827. Epub 2017 May 14.
9
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.多药耐药相关蛋白4(MRP4)可输出前列腺素E2(PGE2),并促进基底样/三阴性乳腺癌的转移。
Oncotarget. 2017 Jan 24;8(4):6540-6554. doi: 10.18632/oncotarget.14145.
10
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.COX-2表达与PIK3CA突变联合作为乳腺癌塞来昔布治疗的预后和预测标志物。
Oncotarget. 2016 Dec 20;7(51):85124-85141. doi: 10.18632/oncotarget.13200.